Delivery Order SPE2DB22D2206-SPE2DB25FFA87

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $48K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,509.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Isosulfan Blue 1% Vial, 5mL, a medical product used in various healthcare applications. The contract has an ultimate completion date of September 27, 2023. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,502.14 firm fixed-price delivery order is for the supply of ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of August 7, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $7,511.64 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560728569 - ISOSULFAN BLUE 1% VIAL 5ML, with a completion date of April 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Isosulfan Blue 1% solution vials. The $38,562.15 Firm Fixed Price delivery order contract has a period of performance through December 12, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,898.29 firm fixed-price delivery order is for the supply of Isosulfan Blue 1% vial, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,770.32 fixed-price contract is for the delivery of Isosulfan Blue 1% Vial 5ML, a medical supply used in various healthcare applications. The contract has a completion date of November 13, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $45,805.88, is for the supply of 4566740512 - ISOSULFAN BLUE 1% VIAL 5ML, a medical product used in various healthcare applications. The contract has a Firm Fixed Price pricing type and a completion date of December 18, 2024. There is no set-aside...
The Defense Logistics Agency (DLA) has awarded a delivery order contract worth $39,170.43 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,450,073 units of 1% Isosulfan Blue Vial (5 mL). This contract has a firm fixed price and an ultimate completion date of May 1, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is a major pharmaceutical supplier to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Isosulfan Blue 1% vial, 5ml. The firm fixed price delivery order, valued at $13,324.77, has a completion date of January 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous contract awards from DLA Troop Support Medical to supply pharmaceuticals, medical supplies, and related...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,742.98 contract is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML, a medical product used in federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFA87
    Delivery Order

This federal contract award, valued at $47,947.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Isosulfan Blue 1% Vial, 5ML, a medical supply item, with a completion date of January 13, 2025.

The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/11/25, 11:32 AM